Phase II clinical trial of high-dose toremifene as primary hormone therapy in aromatase inhibitor-resistant breast cancer.
Ogata H, Okamoto Y, Arima Y, Fukushima H, Takeyama H, Yamashita A, Kinoshita M, Suzuki N, Sawada T, Koshida Y, Matsui A, Tachibana A, Nakayama H, Oishi Y, Nogi H, Uchida K.
Ogata H, et al.
Gan To Kagaku Ryoho. 2013 Jun;40(6):749-53.
Gan To Kagaku Ryoho. 2013.
PMID: 23863651
Clinical Trial.